Search Results - Tiu, R.V.

  • Showing 1 - 9 results of 9
Refine Results
  1. 1
    168 SOMATIC WISKOTT-ALDRICH SYNDROME PROTEIN FAMILY MEMBER 3 (WASF3) MUTATIONS IN MYELODYSPLASTIC SYNDROMES AND RELATED MYELOID MALIGNANCIES

    168 SOMATIC WISKOTT-ALDRICH SYNDROME PROTEIN FAMILY MEMBER 3 (WASF3) MUTATIONS IN MYELODYSPLASTIC SYNDROMES AND RELATED MYELOID MALIGNANCIES by Visconte, V, Tabarroki, A, Zhang, L, Gerds, A.T, Rogers, H.J, Han, Y, Barnard, J, Shivarov, V, Carew, J, Tiu, R.V

    Published in Leukemia research
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    P-010 Distinct methylation signature in MDS patients with SF3B1 mutations confers a novel mechanism of disease pathogenesis

    P-010 Distinct methylation signature in MDS patients with SF3B1 mutations confers a novel mechanism of disease pathogenesis by Visconte, V, Zhang, L, Mahfouz, R, Tabarroki, A, Rogers, H.J, Hasrouni, E, Hamilton, B, Jankowska, A, Barnard, J, Traina, F, Duong, H, Saunthararajah, Y, Lichtin, A, Horwitz, L, Sekeres, M.A, Tiu, R.V

    Published in Leukemia research
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Distinct iron architecture in SF3B1-mutant myelodysplastic syndrome patients is linked to an SLC25A37 splice variant with a retained intron

    Distinct iron architecture in SF3B1-mutant myelodysplastic syndrome patients is linked to an SLC25A37 splice variant with a retained intron by Visconte, V, Avishai, N, Mahfouz, R, Tabarroki, A, Cowen, J, Sharghi-Moshtaghin, R, Hitomi, M, Rogers, H J, Hasrouni, E, Phillips, J, Sekeres, M A, Heuer, A H, Saunthararajah, Y, Barnard, J, Tiu, R V

    Published in Leukemia
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    P035 Improvement in cytogenetic diagnosis and clinical prognostication using SNP-A karyotyping in combination with metaphase cytogenetics in MDS, MDS/MPD and secondary AML

    P035 Improvement in cytogenetic diagnosis and clinical prognostication using SNP-A karyotyping in combination with metaphase cytogenetics in MDS, MDS/MPD and secondary AML by Tiu, R.V, Gondek, L.P, Huh, J, O'Keefe, C, Sekeres, M.A, Mufti, G.J, McDevitt, M.A, Advani, A.S, Maciejewski, J

    Published in Leukemia research
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    P045 TET2 gene harbors mutations associated with myeloid malignancies

    P045 TET2 gene harbors mutations associated with myeloid malignancies by Jankowska, A.M, Szpurka, H, Tiu, R.V, Makishima, H, Afable, M, Huh, J, O'Keefe, C, Ganetzky, R, McDevitt, M.A, Maciejewski, J.P

    Published in Leukemia research
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    C021 SNP-array karyotyping complements routine metaphase cytogenetics in the detection of chromosomal aberrations including uniparental disomy in MDS

    C021 SNP-array karyotyping complements routine metaphase cytogenetics in the detection of chromosomal aberrations including uniparental disomy in MDS by Tiu, R.V, Gondek, L.P, Haddad, A, O'Keefe, C.L, Sekeres, M.A, Sekeres, G, Ogawa, S, Maciejewski, J.P

    Published in Leukemia research
    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    Epidemiology and risk factors for infections in myelodysplastic syndromes

    Epidemiology and risk factors for infections in myelodysplastic syndromes by Sullivan, L.R., Sekeres, M.A., Shrestha, N.K., Maciejewski, J.P., Tiu, R.V., Butler, R., Mossad, S.B.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  8. 8
    Effect of Chromosomal Lesions Detected by SNP-Array Karyotyping on Survival After Allogeneic HCT for MDS and AML

    Effect of Chromosomal Lesions Detected by SNP-Array Karyotyping on Survival After Allogeneic HCT for MDS and AML by Mohan, S.R, Tiu, R.V, Gondek, L.P, O'Keefe, C.L, Kalaycio, M, Sobecks, R.M, Copelan, E.A, Maciejewski, J.P

    Get full text
    Article
    Save to List
    Saved in:
  9. 9
    Differences in Iron Distribution in Patients with Myelodysplastic Syndromes Carrying SF3B1 Mutations Using Energy-dispersive X-ray Spectroscopy (XEDS) and Electron-Energy Loss Spectroscopy (EELS)

    Differences in Iron Distribution in Patients with Myelodysplastic Syndromes Carrying SF3B1 Mutations Using Energy-dispersive X-ray Spectroscopy (XEDS) and Electron-Energy Loss Spec... by Visonte, V., Avishai, N., Sharghi-Moshtaghin, R., Mahfouz, R., Tabarroki, A., Rogers, H.J., Hitomi, M., Hasrouni, E., Hamilton, B.K., Barnard, J., Traina, F., Duong, H.K., Saunthararajah, Y., Sekeres, M.A., Advani, A.S., Heuer, A., Tiu, R.V.

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: